AIM IMMUNOTECH INC (AIM) Stock Cash Flow
NYSEARCA:AIM - NYSE Arca - US00901B1052 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -23.93M | -28.96M | -19.45M | -19.13M | -14.40M | |||
| Depreciation Amortization | 240.00K | 238.00K | 256.00K | 775.00K | 733.00K | |||
| Change In Working Capital | 963.00K | 7.13M | 966.00K | 895.00K | 605.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 2.04M | 326.00K | 2.12M | 3.49M | 2.69M | |||
| OPERATING CASH FLOW | -20.69M | -21.27M | -16.11M | -13.96M | -10.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -585.00K | -271.00K | -633.00K | -595.00K | |||
| Other Investing Activity | 1.00M | -247.00K | 11.26M | 2.00K | -8.57M | |||
| INVESTING CASH FLOW | 788.00K | -832.00K | 10.99M | -631.00K | -9.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -4.85M | -4.68M | |||
| Stock Issued/Repurchased | 3.05M | 485.00K | 80.00K | 13.04M | 61.25M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 5.55M | 485.00K | 80.00K | 8.19M | 56.56M | |||
| CHANGE IN CASH | -14.35M | -21.61M | -5.04M | -6.41M | 37.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.69M | -21.27M | -16.11M | -13.96M | -10.37M | |||
| Capital Expenditure | N/A | -585.00K | -271.00K | -633.00K | -595.00K | |||
| FREE CASH FLOW | -20.91M | -21.85M | -16.38M | -14.60M | -10.96M | |||
All data in USD